| Similar Articles |
|---|
 |
Pharmaceutical Executive
July 1, 2012 |
Country Report: Thailand Indochina's biggest pharmaceutical market has quickly matured over the past years due to the implementation of heavy cost containment measures meant to make healthcare more accessible to the patient.   |
Pharmaceutical Executive
February 1, 2011
Jon Zifferblat |
China: Business as UNusual If there is one market that requires a click on the 'refresh' button, it's China. General Biologic provides a snapshot of what's ahead for Big Pharma in the country |
Pharmaceutical Executive
May 1, 2012 |
Country Report: South Africa In just the past few years, South Africa has hit several key economic benchmarks demonstrating the country's upward trajectory. |
Pharmaceutical Executive
August 1, 2012 |
Country Report: Mexico Jim O'Neill, chief economist at Goldman Sachs declared that by 2020 Mexico would be the seventh largest economy in the world, surpassing both India and Russia. The Mexican pharmaceutical industry has seen some significant changes over the last four years. |
Pharmaceutical Executive
June 9, 2014
Genenz et al. |
Surviving the Price Wars in Emerging Markets: Three Myths and Three Lessons How big Pharma stalwarts can avoid a corrosive battle of attrition with local competitors and instead obtain the long-term goal of a stable pricing environment. |
Pharmaceutical Executive
December 1, 2011 |
UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity. |
Pharmaceutical Executive
June 1, 2011 |
Are You Ready for the New China? The ability to act as a good corporate citizen and assert a useful role in national industrial policy on health is going to be essential to success in the new China. |
Pharmaceutical Executive
March 1, 2013 |
Country Report: China China's pharmaceutical industry is making record gains. Four years ago, China was the world's fifth largest market. Now, it has bypassed France and Germany to become the third largest. |
Pharmaceutical Executive
October 1, 2006
Ray Hill |
China: Big Rewards. Bigger Risks? The world's fastest growing pharmaceutical market may one day be the largest. Breaking in could be industry's greatest challenge. |
Pharmaceutical Executive
October 1, 2010 |
Taking a Less-Generic Route to Generics A leading pharmaceutical industry player speaks out on what is fueling success in the sector. |
Chemistry World
July 25, 2012 |
Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population. |
Pharmaceutical Executive
September 1, 2012
Stan Bernard |
The Payer C Change: From Customers to Competitors "Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets." Understanding why and how this payer shift to dominance occurred is critical for pharmaceutical professionals in adjusting their business model. |
Pharmaceutical Executive
October 1, 2011 |
Pharma Futures: The Next 30 Years Success for the next 30 years in the pharmaceutical industry depends significantly on navigating the myths and mental traps of emerging market strategy. |
Pharmaceutical Executive
December 1, 2008
Jill Wechsler |
Challenge and Challenges Expanded healthcare coverage also fits the goals of pharma manufacturers. |
The Motley Fool
February 22, 2005
Brian Gorman |
Novartis Embraces Generics The company is taking a different path from its branded pharmaceutical peers. The company's strategy may make its stock worth a closer look. |
The Motley Fool
February 10, 2011
Bill Mann |
Indonesia: A Divine Mess Tony Arsta and I were back, seeking investment opportunity in Indonesia, a country and a market quite different than the one I'd left 13 years ago. |
Chemistry World
November 28, 2008
Matt Wilkinson |
EU claims pharma delaying tactics cost 3 billion euros Pharmaceutical manufacturers have been criticised by the EU competition commission for slowing the entry of generic medicines to the market. |
Pharmaceutical Executive
September 1, 2013
William Looney |
High Noon For Hot Markets Fading growth, overstretched governments, and a global governance backlash against pharma business are turning up the heat on the performance of emerging country markets. |
Pharmaceutical Executive
May 1, 2014
Nadeem Rehmat |
Gravity Shift: Timely Lessons For Big Pharma MNCs can learn a lot from generic companies in their strategic approaches to emerging markets. |
Chemistry World
May 2006
Bea Perks |
Editorial: Generics in the Dock The manufacturers of generic medicines in the U.K. must work harder to guard their good reputation. Or perhaps, manufacturers of generic medicines must work harder to counter their bad reputation. |
Pharmaceutical Executive
July 1, 2005
Sarah Houlton |
Global Report: Still Waiting Pharma industry and traders both want a decision on parallel trade in Europe--but not the same one. |
The Motley Fool
June 3, 2008
Ryan Fuhrmann |
An Emerging Market Not to Overlook Indonesia flies under the radar of most Western investors -- and most businesses, for that matter. Here's why we should be paying attention. |
Pharmaceutical Executive
April 1, 2009
Jill Wechsler |
Kickoff for Reform In addition to overhauling healthcare, Congress is weighing proposals for updating FDA policies and expanding access to drugs. |
Pharmaceutical Executive
January 1, 2009
Stan Bernard |
Pharma vs. Pharma The most successful pharmaceutical companies will be those that can transform as the industry itself transforms. |
BusinessWeek
October 18, 2004
Assif Shameen |
The Second-Hottest Car Market In The World As Indonesia's economy revives, auto sales are growing at a pace second only to China's. |
Pharmaceutical Executive
April 1, 2007
Porth & Sillup |
Media Audit: Stop the Presses! The media are becoming more negative and one-sided when it comes to reporting pharmaceutical industry news. |
Pharmaceutical Executive
March 1, 2013 |
China and the Emerging Markets Challenge: Why Big Pharma Must Embrace a New Strategy With health reform already tagged as a key domestic priority, their policies will pose new opportunities and challenges for Big Pharma companies active in China. |
The Motley Fool
December 6, 2004
Brian Gorman |
Pill-Popping Nation Americans are using more prescription drugs. Unfortunately for big pharma investors, pharmaceutical companies' benefits from these trends are tempered by other factors. |
Managed Care
April 2004 |
Headlines on Deadline The least insured of the major medical services is the pharmaceutical benefit, according to the Pharmaceutical Research and Manufacturers of America. |
Pharmaceutical Executive
May 1, 2011
Stan Bernard |
Competition 2.0: Brands vs. Generics Innovator and generics companies are colliding as they invade each other's turf. |
Chemistry World
May 21, 2009
Matt Wilkinson |
Big Pharma set for generics boost Pharmaceutical firms have been rushing to ensure they minimize their losses by expanding their generics businesses and reach into emerging markets. |
Pharmaceutical Executive
March 1, 2009
Porth & Sillup |
Fifth Annual Press Audit: Safety in the Spotlight Reporters pass on the typical litany of lightning-rod issues and instead devote more than three-quarters of all coverage in 2008 to drug safety and the regulators who enforce it. |
The Motley Fool
June 4, 2008
Nathan Parmelee |
Other Ways to Profit From China's Growth Potentially large growth opportunities are taking shape in Southeast Asia. |
Chemistry World
March 25, 2010
Rebecca Trager |
Big pharma scores in US healthcare reform President Obama has signed the biggest US healthcare reform since the 1960s, and although it is largely seen as a victory for the pharmaceutical industry, some analysts are characterising it as a 'double-edged sword'. |
The Motley Fool
November 29, 2010
Eric Dutram |
Indonesia ETFs Head-to-Head: IDX vs. EIDO Indonesia has high levels of consumer spending, which have allowed the nation to weather the financial crisis better than many of its export-dependent neighbors |
Chemistry World
July 16, 2012
Andrew Turley |
Drug spending to hit $1.2tn in 2016 Global expenditure on medicines will top $1.2 trillion in 2016, up from $960 billion in 2011, according to a report from the IMS Institute for Healthcare Informatics. |
BusinessWeek
March 28, 2005
Assif Shameen |
Indonesia: As Growth Heats Up, Buyouts Are Smokin' Multinationals like Philip Morris are moving back into Indonesia |
BusinessWeek
October 31, 2005
Assif Shameen |
Jakarta Puts Its Banks On The Block Banking sector privatization could bring a much-needed $4 billion into the government's coffers. |
BusinessWeek
August 25, 2003
Michael Shari |
Jakarta: "We're Going to Fight" Terror Economics czar Kuntjoro-Jakti acknowledges the challenge but says: "We fought this kind of terrorism in the '50s, and we won." |
BusinessWeek
July 4, 2005
Assif Shameen |
The OPEC Stalwart that Imports Oil Indonesia's oil output has been lagging for years, so it's gunning for foreign investment-fast. And some of the money is already starting to flow. |
The Motley Fool
January 26, 2005
Stephen D. Simpson |
Sanofi's Balancing Act A broad portfolio of drugs helps the French pharmaceutical stay ahead of its peers. It's a good option for investors who want a strong growth stock in the pharmaceutical space but don't want to take on the risks of turnarounds or litigation. |
BusinessWeek
January 21, 2010
Ten Kate & Sukarsono |
The Faceoff over Land in Rural Indonesia Poor farmers are stymieing the government's efforts to build new roads and ports to boost growth |
